Each image underwent rigorous preprocessing and multi-level expert screening before being analyzed by an AI model based on a U-Net architecture. This approach enabled precise segmentation of meibomian ...
Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction AZR-MD-001 0.5% meets co-primary efficacy endpoints, making it the first ...
Artificial intelligence (AI) is increasingly reshaping medical imaging, yet its progress depends heavily on the availability of reliable, well-curated data. In eye health, the lack of standardized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results